case_images: PMC11176459_01
case_images: Immunohistochemistry. (A) Smooth muscle actin; (B) CD31; (C) caldesmon; (D) CD34; (E) proliferative index (Ki-67) is approximately 60%.
case_images: fonc-14-1340859-g001.jpg
case_images: PMC11176459_01_fonc-14-1340859-g001.jpg
case_images: f1
case_images: CD31, SMA, Caldesmon, CD34, and the Ki67 index was 60% ( Figure 1 ). Combined with the history, the presentation was consistent with a malignant glomus tumor.
case_images: Course of the disease with treatment history and images.
case_images: fonc-14-1340859-g002.jpg
case_images: PMC11176459_01_fonc-14-1340859-g002.jpg
case_images: f2
case_images: The latest follow-up and reexamination date is August 25, 2023, indicating that the intrahepatic metastasis has further shrunk, with the largest being about 1.1 * 1.5cm in size, the efficacy was evaluated as PR ( Figure 2 ).